BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that management will participate in fireside chats during the following investor conferences:
- Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 1 p.m. ET in New York, NY
- Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 8 a.m. ET in Miami Beach, FL
Live webcasts will be available in ...